27N0.XETRA Cannovum Cannabis AG

Healthcare Drug Manufacturers - Specialty & Generic XETRA Stock Exchange
0.4650 EUR
Close of Nov 6, 2026
0.2820 0.8640
Market cap
EUR 1.07M
P/E
-
P/B
5.37x
ROE
-132.6%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is 27N0.XETRA undervalued?

Graham number

The Graham number of Cannovum Cannabis AG cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Cannovum Cannabis AG fundamental analysis

No fundamental analysis for Cannovum Cannabis AG yet.

Cannovum Cannabis AG stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Cannovum Cannabis AG

Cannovum Cannabis AG engages in the manufacturing, wholesaling, and importing of medical cannabis products in Berlin. It also focuses on the import of medical cannabis and medical-scientific education, as well as distribution for facilitated access to cannabis-based therapies. The company was formerly known as Cannovum AG and changed its name to Cannovum Cannabis AG in April 2023. Cannovum Cannabis AG was incorporated in 2018 and is based in Berlin, Germany.

Full company profile